Overview
- 49 inspections across 48 sites are on record.
- 70 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-02-26.
At a glance
Inspections
49
Sites
48
Observations
70
Career since
Oct 2020
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Smith & Nephew Wound Management | 26 Feb 2026 | Human Drugs | On file |
| Novartis Manufacturing LLC | 16 Jan 2026 | Human Drugs | |
| Nippon Fine Chemical Co., Ltd. | 14 Nov 2025 | Human Drugs | On file |
| Sucampo Pharma, LLC | 7 Nov 2025 | Human Drugs | On file |
| Sumitomo Chemical Co., Ltd. | 31 Oct 2025 | Human Drugs | On file |
Sites inspected
Smith & Nephew Wound ManagementFort Worth, United States1 insp.
Novartis Manufacturing LLCCarlsbad, United States1 insp.
Nippon Fine Chemical Co., Ltd.Takasago, Japan1 insp.
Sucampo Pharma, LLCSanda, Japan1 insp.
Sumitomo Chemical Co., Ltd.Anpachi-Gun, Japan1 insp.
Co-investigators
Investigators who share inspections with this person.
Crystal Monroy5 shared
Joel D Hustedt4 shared
Jacob G Lutz3 shared
Linda Thai2 shared
Pamela N Agaba2 shared
Bryan A Galvez2 shared
Qiang Han1 shared
Cecilia H Kieu1 shared
Truong X Nguyen1 shared
Walden H Lee1 shared
Full investigator report
Get the verbatim findings behind Gavin T Cua's 70 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site